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It  has been  repeatedly shown  that vaccination with BCG can  induce  a 
definite,  although limited,  level of antituberculous immunity in experimental 
animals. But,  though the principle  of BCG vaccination is widely accepted, 
almost all its practical aspects  have been the subject of endless controversies. 
These involve the stability of the BCG strain, the techniques  of preparation 
and preservation of the vaccine,  the procedures  used for its administration, 
the extent and duration of the immunity induced, etc. 
Investigation of the problems  of antituberculous immunity has been  ren- 
dered more difficult by the lack of simple and dependable  experimental  tech- 
niques for the assessment of the protective effects of vaccination. The measure- 
ment of tuberculin hypersensitivity in vaccinated individuals  is a convenient 
technique  for establishing  that the vaccine  has  "taken," but unfortunately, 
it provides  no information concerning  the development of immunity in the 
vaccinated  individual.  Despite  many assertions,  there  is  no  evidence  that 
tuberculin allergy and immunity to infection follow parallel  courses and that 
the former can be used as an index of the latter. Indeed, there are many reports 
in the literature showing that a high level of allergy can exist in the absence 
of immunity to infection and vice versa. 
Guinea pigs or rabbits have of course been used extensively for the perform- 
ance  of protection tests which  have provided fundamental information for 
the study of some of the phenomena of immunity. Unfortunately, vaccination 
increases only to a slight degree their resistance  to tuberculosis,  and for this 
reason results of statistical significance can be obtained only by the use of large 
numbers of animals. Because of cost, space required,  and other practical limi- 
tations, these large rodents therefore hardly  lend themselves to studies involving 
the use of multiple parameters. Yet, analysis of the development of the im- 
mune state demands that many factors be taken into consideration.  The in- 
trinsic properties  of the strain used in the preparation of the vaccine, the age 
and other physiological characteristics  of the bacilli, the dose both of vaccine 
and of challenge infection,  the time between  vaccination and infection,  the 
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effect of the tissue environment on the response of the body to the vaccine, 
all these and many other factors influence greatly the results of vaccination. 
In  all  other  fields  of  immunological experimentation,  progress  has  been 
accelerated and techniques have become more quantitative as soon as it has 
been possible to reproduce some of the immune reactions in a convenient and 
inexpensive experimental system. Since no technique is yet available for the 
passive transfer of antituberculous immunity or for its study in vitro, it is 
necessary at the present time to attack the problem by means of active im- 
munization of animals. 
There are on record in the literature a number of studies showing that mice 
can acquire a certain degree of resistance to tuberculosis following vaccination 
with attenuated or killed cultures of tubercle bacilli. True enough, the  im- 
munity thus obtained is of a low order, but not unlike that reported in guinea 
pigs  or  rabbits.  As  a  complete  and  critical  analysis of these  immunization 
experiments has been recently presented by Swedberg (1),  they need not be 
reviewed here. In general, immunity in mice has been measured in terms of 
increased survival time of the vaccinated animals over that of controls after 
challenge infection  with virulent bacilli. The differences observed with this tech- 
nique have been so slight as to require statistical analysis to give them validity. 
More recently, Siebenmann tried to compare by direct microscopic examina- 
tion the numbers of bacilli present in the organs of infected mice (2). These 
results  showed  clearly  that  the  multiplication of virulent bacilli was  more 
abundant in the lungs, liver, and spleen of control mice than in the organs of 
animals vaccinated  subcutaneously with  BCG. 
In  the  present  study,  an  attempt  was  made  to  analyze by  quantitative 
bacteriological techniques the effect of some of the factors which can be as- 
sumed to play a part in the immunization of mice with attenuated cultures of 
tubercle bacilli. 
Experimental Methods 
The cultures, media, and techniques used were those described in an accompanying paper 
(3). 
RESULTS 
Effect of Vaccination with Attenuated Cultures of Tubercle Bacilli on the Sur- 
vival of Mice Subsequently Infected with Large Doses of Virulent Culture.--The 
most simple and most conclusive evidence of immunity is the ability of the 
vaccinated animal to  survive infection with doses of virulent culture lethal 
for unvaccinated controls. During the early stages of the present study, several 
virulent cultures of human and bovine type were used in different doses for 
the challenge infection of the vaccinated animals. The strain MV was finally 
adopted in preference to the others because it is highly virulent and easy to 
cultivate. Doses ranging from 0.05 to 0.2 ml. of 7 to 10 day old cultures of this R.  J.  DUBOS,  C.  H.  PIERCE,  AND  W.  B.  SCHAEFER  209 
strain in tween-albumin medium were found sufficient to kill within 10  to 20 
days mice 3  to  10  weeks  of  age;  the  younger  the  animal,  the  smaller  the 
lethal dose. The survival time could be increased approximately two- or three- 
fold by decreasing the infective dose to one-half or one-third, but  the differ- 
ences in survival time between vaccinated and  control animals were not ren- 
dered  more  clean  cut  thereby.  Although  certain  breeds  of  pigmented  mice 
proved more susceptible than  the albino animals,  the latter were  chosen for 
reasons of convenience in the present study, and large doses (usually 0.2 ml.) 
of culture were selected for the challenge infection in order to accelerate the 
test. 
A  first experiment was designed to test the effect of the level of atttenuation 
of the culture used for vaccination on the resistance of mice to virulent infec- 
tion. Four cultures were compared. Three of these, RIRv, BCG-P, and BCG-T, 
have been shown to be able to multiply in the mouse, but to different extents. 
By contrast, the fourth culture, H37Ra, seems unable to multiply in vivo (3). 
Since it has been shown in the preceding paper that the maximum population 
levels reached in the organs of the mouse by attenuated cultures are dependent 
on the route of injection, a  comparison was  also made  of  the  efficacy of  the 
intraperitoneal and intravenous routes for vaccination. 
Mice were vaccinated with 0.2 X  10  -~ ml. or 0.2  X  10-  s ml. of one of the four cultures 
used as vaccine. The smaller dose (0.2 X  10  -4 mi.) was used for the two strains (R1Rv and 
BCG-P) shown earlier to multiply extensively in mice (3), whereas  the larger dose (0.2 X 
10-  s ml.) was used for both the strain BCG-T (which multiplies only little in dvo)  and for 
H37Ra (which does not multiply in vivo). In each case, half the mice received the vaccinating 
dose intraperitoneally and  the other half intravenously. Mice receiving  only the diluent 
(0,1 per cent albumin) either intraperitoneally or intravenously served as controls.  2 weeks 
later, all the animals were infected intravenously with 0.2 ml. of virulent culture MV. The 
survival time (in days) for each animal is presented in Table I. 
Another experiment was  done  to  test  the  effect of  the  dose of  BCG  (ad- 
ministered intravenously) and of the length of time between vaccination and 
challenge infection (2 to 4  weeks) on the development of immunity against a 
large infective dose. Two substrains of BCG were used in comparison. 
Mice were vaccinated by the intravenous route with either 0.2 X  10  -2 or 0.2 X  10  -4 ml. 
of BCG culture. The substrains of BCG used were BCG-P and BCG-T; the cultures of these 
two substrains were of the same age and had approximately the same optical density. Half 
of the animals were challenged 2 weeks after vaccination by the intravenous injection of 0.2 
ml. of the virulent culture MY (grown in a medium containing human serum albumin instead 
of bovine serum albumin to avoid allergic reactions). The other half of the vaccinated animals 
received  a  similar virulent infection 4 weeks after vaccination. In each ease, control mice 
having received the diluent instead of the BCG suspension were similarly infected.  The sur- 
vival time (in days) of animals in the different groups is given in Table II. 
The  results presented  in  Tables  I  and  II  show  dearly that  whatever  the 
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TABLE I 
E.~ect of Roule of Vaccination and of the Attenuation  of the Vacdne  Strain Used on Resista~x.e 
after Infection  with Large Doses of Virulent  Tuberde Bacilli 
Vaccination 
Strain  !  Dose 
RIRv,,  0,2 ,X, 10-' 
BCG-P.  0.2  ,X/10-* 
BCG~T  0.2 ,X, 10-1 
H37Ra,,  0.2 ,X, 10"1 
ContTols 
Diluent  0.2 
C~rol 
Diluent  " 
Route 
Intravenous 
Intrape~toneal 
Intravenous 
Intraperitoneal 
Intravenous 
IntraperitoneaI 
lnUavenous 
Intraperitoneal 
Intravenous 
Intraperitoncal! 
Survival time of mice infected with 0.2 ml. of 
virulent culture MV 2 wks. after vaccination 
days 
20  28  28  33  33  33  S*  S  S  S 
16  25  25  28  29  33  33  33 
20  22  23  25  28  33  33  S  S  S 
16  16  16  19  19  19  20  20  20  23 
21  22  22  26  26  30  33  33  33 
12  14  16  16  16  16  16  19  19  21 
19  19  19  19  20  25  25  27  33 
16  16  16  16  19  19  19  19  19 
16  16  16  19  19  19  20  20  20  21 
16  16  16  16  19  19  19  19  19  19 
Average 
survival 
time 
days 
31 
28 
29 
19 
27 
17 
22 
18 
19 
18 
* S indicates that animals were still surviving when the experiment was terminated on the ~th day after 
challenge infection. 
TABLE II 
Effect o/Vaccination on the Surtival of Mice Infected with 02 Ml. o/Virulent Culture MV 
Vaccine  intravenous) 
Strain  Dose 
BCG-T  0.2  X  I0  -~ 
"  0.2  X  10  -4 
BCG-P  0.2  X  10  -I 
"  0.2  X  10-' 
Diluent  0.2 
BCG-T  0.2  X  10  -~ 
"  0.2  X  10  -4 
BCG-P  0.2 X 10  -~ 
"  0.2  X  10-' 
Diluent  I 0.2 
Time 
between 
vaccination 
~nd chslhnge 
infection 
days 
15 
gl 
28 
ct 
Survival time following challenge infection 
(intravenous) with 0.Z mL MV 
days 
12  12  13  17  17  17  20  21  24  25 
10  13  14  17  17  17  17  18  18  18 
10  11  11  17  17  21  24  24  24  24 
10  12  14  14  17  17  17  20  21  25 
10  10  10  10  11  12  12  13  14  14 
11  11  14  21  22  22  25  25  25  27 
11  15  15  21  21  21  21  21  22  S* 
14  15  21  21  22  25  27  27  S  S 
11  13  13  14  21  21  22  27  S  S 
11  12  13  14  15  21  21  21  21  21 
Average 
survival 
time 
days 
18 
16 
18 
17 
12 
20 
20 
23 
20 
17 
*S indicates that animals were still surviving when the experiment was terminated  on 
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the route of vaccination (intravenous or intraperitoneal), and whatever the 
length of time elapsed between vaccination and challenge infection  (2 weeks 
or 4 weeks),  the immunity induced was never sufficient to protect the vac- 
cinated animals against death from virulent infection. At most, it prolonged 
their survival  time by less than  twofold. 
Moreover,  there was in many cases overlapping  of the number of days of 
survival time between  the control and the vaccinated groups. As the groups 
were small (10 animals or less), some of the results have only a questionable 
significance. Nevertheless,  a few conclusions appear justified,  and have been 
confirmed by the results of other similar experiments  not reported here. 
In all cases, administration of the vaccine  by the intravenous route was 
more effective than by the intraperitoneal route. This difference is probably 
related to the fact that with the doses of vaccine used,  the bacilli of the vac- 
cine multiplied much more extensively in vivo when they were injected intra- 
venously rather than intraperitoneally (3). In fact, introduction of the vaccine 
by the intraperitoneal route resulted in a  significant  level of immunity only 
in the case of the attenuated culture R1Rv. It will be remembered  that of the 
attenuated cultures studied, R1Rv was the one which multiplied most exten- 
sively in ~ivo, particularly following intraperitoneal inoculation  (3). 
Whereas R1Rv was the most effective vaccinating agent under the condi- 
tions of the test, H37Ra was the least effective. In fact, it failed to elicit any 
significant immunity whether injected by the intraperitoneal or by the intra- 
venous route,  and  this,  despite  the  fact  that  the amount injected  (0.2 X 
10  -a ml.)  was ten times larger  than the amount used in the case of cultures 
R1Rv and BCG-P. The failure of H37Ra to elicit immunity under the condi- 
tions of the test is certainly a reflection of the fact that this strain is not ca- 
pable  of multiplying in  vivo (3). 
The two BCG substrains tested (BCG-P and BCG-T) were more effective 
than H37Ra, but less effective than R1Rv (Table I), a  finding  in agreement 
with the fact that they multiply in ~ivo less extensively than the latter culture. 
Multiplication  o/Virulent Tubercle Bacilli  in the Spleen and Lungs of Mice 
Vaccinated uritk BCG.--As pointed out in a preceding paragraph, it is difficult 
to assess the effect of vaccination with attenuated cultures from a comparison 
of the length of survival time of vaccinated animals with that of the controls. 
The differences observed were always small, and there was often much over- 
lapping,  thus rendering  the results inconclusive in many cases. Experiments 
were  therefore  instituted to determine whether immunity could  be assessed 
by another technique,  namely in terms of its effect on the multiplication of 
small doses of virulent bacilli in the organs of mice. 
Several independent variables  were introduced in the following experiment. 
Two different substrains of BCG were used, different doses of vaccine, differ- 
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collected included the number d  BCG bacilli in the organs of mice at the time 
of  the  challenge virulent  infection,  and  the  number  of virulent  bacilli that 
could be recovered from the spleen and lungs of mice sacrificed 2 weeks after 
virulent infection. 
Mice were vaccinated by the intravenous route with either one of the two BCG substrains 
(BCG-P and BCG-T). In the case of each substrain, three doses of vaccine were used: 0.2 
10  "a, 0.2 X  10  -4, and 0.2 X  10  -6 ml. for BCG-P, and 0.2 X  10  -t, 0.2 X  10% and 0.2 X  10  -4 
ml.  for BCG-T.  Other  mice  receiving  only the diluent served as unvaccinated controls. 
Three mice of each group were sacrificed 2, 3, 5, 7, 10, 14, and 17 weeks after vaccination. 
The number of BCG bacilli in the spleen and lungs was determined by the usual technique. 
On the same day, four other mice of each group were infected with 0.2 X  10  -5 ml. of the 
virulent culture MV. 2 weeks later, these mice were sacrificed and the number of living bacilli 
in their spleen and lungs determined. For the sake of brevity, only the data pertaining to 
the 2 week, 7 week, and 14 week periods are presented in Table HI. Fig. 1 gives in a  dia- 
grammatic form the trend of the bacterial populations in the spleens of the different groups 
of mice over the whole period of observation (17 weeks). Results are plotted for the 0.2 X  10  -a 
ml. dose of vaccine. 
In the case of mice vaccinated with BCG-T and challenged  with virulent bacilli MV, 
differences in colonial  morphology made it possible  to distinguish on the agar plates the 
colonies of BCG from those of the virulent strain. The figures reported in Table IH for this 
group of mice (and the values used for preparing Fig. 1) refer only to the colonies of virulent 
bacilli. 
In the case of mice vaccinated with BCG-P and challenged with the virulent MV bacilli, 
it was not judged possible to differentiate between the two types of colonies with certainty. 
Hence the figures for the numbers of colonies recovered from mlce vaccinated with BCG-P 
and challenged with MV include the two types of colonies. The numbers of BCG colonies 
recovered from mice not infected with MV are indicated in the left portion of Table III. 
The  results presented in Table  III  and  Fig.  1  reveal that  virulent bacilli 
had multiplied much  more abundantly in the  control mice  than  in the mice 
which had been vaccinated with 0.2  X  10  -3 or 0.2  X  10"*  ml. of vaccine 2 
weeks before challenge infection. The  difference between  control groups and 
the  groups  vaccinated with  BCG-P  appears particularly striking when  it is 
remembered that  the colonies recovered from the latter include not only the 
virulent bacilli, but also the BCG bacilli used for vaccination (figures in the 
left  columns  of Table  HI). 
It took longer, (5 to 7 weeks) for immunity to become manifest in the groups 
of mice which  received smaller doses of vaccine. With the larger doses it was 
not possible to detect any difference between the levels of immunity induced 
by the two BCG substrains. But it will be noted that 0.2 X  10  -4 ml. of BCG-T 
was less effective than the same dose or even than 0.2  X  10  -'5 ml. of BCG-P. 
The  differences between  the  two became apparent when  the challenge infec- 
tion was given 10 weeks or later after vaccination. This finding is to be related 
to the fact that, in agreement with the results of earlier experiments,  BCG-P 
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Duration  of Immunity Induced in Mice  by  Vaccination with BCG.--In  the 
preceding  experiment,  it was  found that mice  infected with virulent bacilli 
TABLE llI 
Effect of Strain of BCG, Dose, and Time after Vaccination on the Level of Antltuberculons 
Immunity 
Strain  vaccmaUon '  ,n  ]¢t  u  ~  I  0.2 X  10-~ ml. virulent MV 
Time  j  No. (X i0- )  of  colomes of  ~  •  •  v  •  ,.__B~,~.  .l  u  No.(XI0  )ofcolomesrecoveredfrommlce2  netweeu  acclnadu~  ~,,~r  uacl u  •  •  •  •  "  :  mic  ~ ~t ":me hi  wks. after challenge mfecUon with 
Dose  and  challenge infection 
challenge 
,  infection  Sple~-~n i--~g  s  Spleen  Lungs 
B--CG-.T  ....  I ....  ~d.  i  56~  52  50  10t  9  0.2 X  I0-~  '  2 wks.  90  70  .42  26  22  -- 
(56000)*  7  "  6  2  2  t  4  2  0  480  I10  88  20  2  0 
14  "  0  0  0  0  0  0  460  390  230  16  10 
BCG-T  0.2 X  i0"~  2 wks.  18  12  --  I  2  0  370  380  310  30  24  22 
(5600)  7  "  0  0  0  0  0  480  --  64  2 
14  '¢  .....  520  380  4 
BCG-T  /0.2  X  10-'  2wks.  0  00  (  0  0  3,200  2,400  600  680  240 
I 
(560)  7  "  0  0  0  4  0  660  650  300280  16  12 
14  "  1,150  390  18  0  0 
BCG-P  /  0.2 M  10-'  2 wks.  700  340  66  I  30  6  420  190  82  260  210  126 
/ 
(6400)  7  "  190  3630  /  34  !0  76  52  14006  28  12 
14  "  12  10  I  6  ~  42  18  0  0  0 
BCG-P  /  0.2 X  10-*  2wks.  70  5046112  4  4,100  3,400  480  310  30  20 
/ 
(64o)  7  "  4  4  2  48  2822  [  64  --  108  I06  4 
14  "  4  2  2  /  0  --  48  26 
I 
14  "  132  74  34  0  0 
Control 1 
Diluent  0.2  2wks.  13,500  13,100  12,400  6,000  5,500  4,800 
7  "  4,300  4,300  3,800  610  370  26 
14  "  6,000  4,500  3,900  222  50  0 
In the mice challenged after vaccination with BCG-T the figures represent the numbers of virulent bacilli 
(MV) recovered, whereas in the groups challenged after vaccination with BCG-P, the figures represent the total 
of virulent bacilli (MV) and vaccinating bacilli (BCG-P). See text for explanation. 
--,  the count was unavailable for technical reasons. 
* Figures in parentheses indicate numbers of viable bacillary units (single cells or clumps) present in the vol- 
ume of vaccine used (as determined by plate counts on albumin agar). 
;[: The figures in the table, when multiplied by i00, give the calculated numbers of colonies of tubercle bacilli 
that could be recovered on albumin agar per whole organ. (Each figure corresponds to the average of two platings 
per mouse.) 
as late as 17 weeks after vaccination with BCG still displayed marked anti- 
tuberculous immunity (see Fig. 1); results for the  17 week period have been 
omitted from Table III. The duration of the immunity is illustrated by another 
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! 
10  6'  0  Diluent.,....  -, 
beg  inject~ 
~fo~  gv~t 
challenge  h~  15  C  D  E 
I  I  I  I  I  I  I  t  I 
Weeks  2  3  4  .  5  .  5  7  8  9  10  16  17 
Inter~al between :BCG inoculation and. challenge ~ith viPulent tubePcle bacilli 
*A,~,C,I~E,F  indicate  individual  9coups  o~  mice  all  r,~alle,  nged i.v.  'with  0.2  x10"Scc,  o~  HV 
Each gpoup o~  mice wa~ ~acoificed.  two  week~ afte~  cl~len~e 
FIO. 1. Recovery of virulent  tubercle  bacilli  (MV) from mice infected  at various intervals 
after  vaccination with living  BCG-T  or BCG-P. The figures  plotted on the curves represent 
the average number of colonies  obtained per spleen from groups of 3 mice. The animals were 
challenged by intravenous injection  of 0.2 X  10  -i ml. of MV  at the times indicated in the 
chart and were sacriSccd 2 weeks later. 
TABLE  IV 
Duration of Immunity Ind~ed by Intraperitoneal  Va~clnatgon with 0.2 X  10  -a MI. of Living 
BCG-P 
Time after 
infection 
with 0,2  )< 
lO-S mL 
MV 
days 
1 
8 
14 
32 
56 
No. (X 10  -s) of colonies  recovered from spleen or lungs of 
Unvaccinated mice 
Spleen  Lungs 
0  0  0 
6  0  0 
1,070  560  220 
1,400  960  570 
500  260  220 
0  0 
0  0 
--  0 
200  500 
190  t900 
0  1 
2  2 
11  0 
440  420 
740  560 
Mice challenged  2 wks. after vaccination 
01210*  170  96  9  310  4  0  -- 
0155  138  99  71  18  13  10  1 
0  86  84  28  --  35  7  6  -- 
~i160  72  61  34  76  63  1 
0 i  57  50  38  30  32  30  30  21 
In the mice challenged after vaccination with BCG-P, the figures represent the total of 
virulent bacilli (MV) and vaccinating bacilli (BCG-P). See text for explanation. 
--,  the count was unavailable for technical reasons. 
* The figures in the table, when multiplied by 100, give the calculated numbers of colonies 
of  tubercle bacilli that would  be recovered on oleic acid-albumin agar per whole organ. 
(Each figure corresponds to the average of two platings per mouse.) 
Mice were infected by the intraperitoneal route with 0.2  X  10  -~ ml. of culture BCG-P. 
The unvaccinated controls received 0.2  mi.  of diluent instead.  2  weeks later,  all animals 
were infected by the intravenous route with 0.2 ×  10  -6 mi. of the virulent culture MV. Three 
controls and three vaccinated animals were sacrificed after 1, 8,  14, 32, and 56 days. The 
numbers of living baciR(in the spleen and in the lungs were determined by the usual tech- 
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In confirmation of the results of earlier experiments (3), the numbers of living 
virulent bacilli in the spleens of the control animals reached a  maximum some 
2 weeks after infection, and then remained more or less stationary. By contrast, 
the numbers of bacilli in the lung did not become large until after the 4th week. 
In the vaccinated animals appreciable numbers of bacilli could be recovered 
from the  spleens  and  lungs  the very  first  day  after  the  challenge  infection, 
but  these  bacilli  evidently  were  the  BCG organisms  that  had  been  used  for 
vaccination (the vaccinating dose was large, 0.2  X  l0  -~ ml.)  since there were 
no virulent MV colonies recovered at this period from mice which had not been 
vaccinated.  The numbers  of bacterial  colonies recovered from the vaccinated 
animals  did  not increase  at  any  time  throughout  the  period  of observation; 
even  though  the  bacterial  population  included  both  BCG  and  the  virulent 
bacilli,  it was still  far smaller  than  in the non-vaccinated mice 56 days after 
infection. 
Effect  of Treatment  with Isoniazid on the Development of Immunity in Mice 
Vaccinated with the Attenuated  Culture RIRv.--If it be true as appears from the 
results presented in this report that the antituberculous ~mmunity induced by 
attenuated  living  cultures  is  an  expression  of the extent  of multiplication  of 
these cultures in the vaccinated animals, it should be possible to interfere with 
the  development  of immunity  by  treating  the  animals  with  a  suitable  anti- 
bacterial drug shortly after vaccination. Isonicotinic acid hydrazide (isoniazid) 
is such a  substance. Using it, this hypothesis has been put to test in the follow- 
hag experiments. 
On April 22, 1952, 48 mice received by the intraperitoneal  route 0.2 X  10  -~ ml. of the 
attenuated culture R1Rv; 16 animals received the diluent instead. On April 23,  1952, i.e. on 
the day after vaccination,  16 of the vaccinated mice received by the intraperitoneal  route 1 
mg. (in 0.5 ml.) of isonicotinic acid hydrazide  (isoniazid). Therapy was continued until May 
9, 1952, i.e. for 18 days, by supplying the drug in the diet at a dosage of approximately  1.0 
rag. daily (the diet had the following composition: desiccated skimmed milk, 330 gin.; white 
wheat flour, 660 gin.; salt mixture,  10 gm.; isoniazid, 0.5 gm. added in solution in  1000 hal. 
of 15 per cent gelatin). 
On April 28, 1952, i.e. 6 days after vaccination, another group of 16 vaccinated mice was 
also started on isoniazid diet, which was also continued until May 9, 1952, i.e. for 12 days. 
The third group of 16 mice was placed on isoniazid diet on May 2, 1952, i.e. ll days after 
vaccination, and continued until May 9, 1952, (7 days of therapy). Half of the non-vaccinated 
mice received the drug from May 2, 1952, to May 9, 1952. The animals of each of the groups 
(vaccinated and controls) were divided into four subgroups. In each case, a first subgroup was 
infected by the intravenous  route with 0.2 X  i0  -s ml. of virulent  culture, on May 12, 1952; 
a second, on May 19, 1952; a third,  on May 26, 1952; and the fourth on June 2, 1952. In 
other words, the challenge infection for each of the four subgroups was given 3, 4, 5, and 6 
weeks after vaccination; i.e., 3, 10, 17, and 24 days after cessation of isoniazid therapy. 
The mice were sacrificed 2 weeks after  the challenge infection. The numbers of bacterial 
colonies recovered from their spleens and lungs are given in Table V. 
Similar groups  and subgroups  received the vaccinating  dose and the isoniazid therapy 
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mice were not infected with virulent bacilli. The animals of each subgroup were sacrificed at 
the same time when those of the duplicate  subgroup received the challenge infection. This 
permitted  the determination  of the number of R1Rv bacilli in the spleen and lungs of the 
vaccinated animals at the time of the challenge infection. These numbers are also presented 
in Table  V (in parentheses). 
TABLE V 
Effect of Treatment with Isoniazid  on Devdopment of Immunity in  Mice  Vaccinated with 
0.2 X  10  -~ ML RIRv 
~-roup 
II 
III 
IV 
V 
Date of  Dates of 
vaccination  treatment 
with 
with RIRv  isoniazid 
4/22/52  4/23/52 to 
5/9/52 
4/22/52  4/28/52 to 
5/9/52 
4/22/52  5/2/52 to 
No vaccina- 
tion 
No vaccina- 
tion 
806 
5/9/52  (4) 
5/2/52 to  tl,850 
5/9/52 
No treat- 
ment 
No. (X 10  ~) of bacterial colonies recovered  from mice sacrificed 
2 wks. after having been challenged with virulent MV at 
following times after vaccination 
3 wks.  4 wks. 
Spleen  Lungs Spleen 
4,266"~1,656  5, 
(o), 
2,010  1,166  ]1,900 
(0)  (0)  (0) 
210  606 
(0)  (4) 
950  ~3,350 
3,684  1,304  4,750 
I 
Lungs 
8,932 
(o) 
2,210 
(o) 
(0) 
2,720 
6,116 
Spleen I Lungs  Spleen 
1,514  274  1,910 
(o)  (2)  (o) 
712  340  118 
(0)  (0)  (32) 
190  8  60 
(72)  (2)  (412) 
i 
5  wka.  6 wks. 
Lungs 
530 
(18) 
6O 
(6) 
92 
(76) 
1,732 
3,100 
!1,776 1,866  1,160 
I 
1  I 
12,810  1,350  882 
I 
F 
--, the count was unavailable for technical reasons. 
* The figures in the table, when multiplied by 100, give the calculated numbers of colonies 
of tubercle bacilli that would be recovered on oleic acid-aibumin  agar per whole organ. (Each 
figure corresponds to the average for four mice--duplicate platings.) 
The figures in parentheses  represent the numbers of colonies of R1Rv recovered from a 
duplicate  set of mice which had been vaccinated  but not challenged and were sacrificed at 
the time of challenge infection of the other set. 
It is obvious,  (Table V)  that the drug isoniazid exerted  a  marked antibac- 
terial effect on R1Rv. No data are available in the case of this particular experi- 
ment concerning the multiplication of the R1Rv bacilli in the mice not receiving 
the isoniazid therapy. However, it is known from earlier experiments that the 
numbers in the spleen and lungs 3 to 6 weeks after vaccination were certainly 
large.  By contrast,  hardly any R1Rv bacilli  (figures in parentheses  in Table 
V)  could be recovered at first from the groups of mice treated  with the drug. 
But  2  weeks  after  cessation  of therapy,  the  R1Rv bacilli  began  to  appear, 
first  in  the  group of mice which had remained  without  therapy for the  first R.  J.  DUBOS,  C.  H.  PIERCE,  AND  W.  B.  SCHAEFER  217 
10 days after vaccination (group III), then in the group in which the therapy 
had been delayed only 6 days (group II). Thus, although therapy begun shortly 
after injection of the RIRv bacilli and continued for'several days had  greatly 
retarded bacterial multiplication, it had not been able to completely eradicate 
the bacilli from the tissues,  since they began to multiply again after withdrawal 
of the drug. This complex situation is reflected in the development of immunity. 
When mice were challenged  with virulent infection on May 12, 1952, i.e. 3 
days after withdrawal  of  the  drug,  only those of group  III  exhibited  some 
evidence of immunity. It seems certain that during the first 12 days without 
therapy  (April  22,  1952 to May 2,  1952) sufficient  multiplication  of R1Rv 
had taken place to initiate the immunization process in this group. 
In mice challenged  5 weeks after vaccination,  immunity had become very 
striking in group III and was becoming manifest in group II. Although R1Rv 
bacilli could not be recovered from mice of group II at  the time that  these 
received  the  virulent  culture  MV it  is  apparent  that  multiplication  of the 
vaccine was then beginning  in these animals,  as indicated by the fact that the 
R1Rv bacilli could be readily  recovered from  the lungs  and  spleen of mice 
of the same group sacrificed  1 week later. 
Immunity was fully evident in mice of groups II and III infected with viru- 
lent bacilli 6  weeks after vaccination.  However, it had not yet appeared in 
group I  which had been treated with isoniazid  immediately after vaccination, 
and in which the R1Rv bacilli had not had time to multiply sufficiently at the 
time of the challenge infection  to elicit an immune response. 
DISCUSSION 
Mice vaccinated with living tubercle bacilli of the "attenuated" type rapidly 
developed partial  resistance against infection with virulent bacilli.  Under the 
conditions of the experiments described in the present paper the numbers of 
living virulent bacilli that could be recovered from the spleen of the vaccinated 
animals 2 weeks after infection were some ten times smaller  than the numbers 
recovered from the organs of the control mice. The data presented also suggest 
that  the spread among  the numbers of bacilli  in the lungs of the vaccinated 
and  non-vaccinated  animals  became greater  with  time as  the  infection  pro- 
gressed.  This conclusion  will be documented more fully in reports to follow. 
The immunity induced by vaccination was directly related to the extent of 
multiplication of the attenuated culture in the tissues of the vaccinated animal, 
as  indicated  by the  following  facts. 
(a)  No  immunity  could  be  detected  following  vaccination  with  cultures 
of the "attenuated" strain H37Ra, which had been found unable  to multiply 
in the mouse.  1 
Seemingly this statement is in contradiction with the results presented in the following 
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(b)  Small  doses of culture of attenuated  strains  proved far more effective 
in  eliciting  immunity  when  injected by the  intravenous  route  than  by the 
intraperitoneal  route, a finding  which faUs in with the fact that the numbers 
of bacilli recovered from the spleen and lungs of mice were greater when the 
culture was injected intravenously.  In unpublished experiments it has been 
found that  the subcutaneous and intramuscular  routes were notably ineffec- 
tive for infecting  mice with attenuated bacilli.  Similarly,  these routes proved 
very ineffective for the production of immunity. It is true that other workers 
in the past have obtained definite evidence of immunity in mice vaccinated 
by the subcutaneous route (1, 2), but the amounts of vaccine that they used 
were very large, of the order of a thousandfold those used in the present study. 
(c) When very small doses of vaccine were used, of the order of 10  -5 ml., 
it took several weeks for the immune state to become established. This period 
corresponded to that required for the establishment of a su~cient population 
level of the attenuated culture in the vaccinated animal. 
(d) The less attenuated the culture used as vaccine, Le. the higher the popu- 
lation level which it reached in the mouse, the more effective it was as a vac- 
cinating agent. This conclusion  had been reached by Trudeau some 50 years 
ago on the basis of immunization experiments in guinea pigs and rabbits (8), 
with strains (other than BCG) of various degrees of virulence,  and it has since 
been confirmed  by other workers (1, 9,  10). 
By the proper  manipulation  of variables  (dose of vaccine,  route of vac- 
cination,  time  after vaccination)  it was possible to  demonstrate  differences 
between the two substrains of BCG tested; the substrain which proved the 
more effective in eliciting  immunity being also the one which multiplied more 
extensively gn d~o. 
(e) The  development of the immune  state following  vaccination could be 
retarded or completely prevented by treatment of the mice in course of im- 
munization  with  isonicotinic  acid  hydrazide. 
By the use of the proper experimental technique, it was possible without fail 
to demonstrate  that  vaccination with  cultures of attenuated bacilli induced 
in  mice a  state  of increased  resistance  to virulent  tubercle bacilli.  But the 
immune mechanism  was only partially effective.  In  no case did it result in 
death of the virulent bacilli;  it only retarded or at best interrupted their mul- 
tiplication.  In no case were the vaccinated animals  protected against  death 
from infection with large doses; they only survived somewhat longer than the 
killed H37Ra bacilli, only when the amount of bacillary material  injected was very much 
larger (a  1000-fold)  than the mount of ling bacterial culture used  in the present study. 
Authors who have been  successful  in obtaining anfituberculous  immunity by vaccinating 
guinea pigs with living cultures of H37Ra (5, 6, 7) used amounts of culture much in excess of 
those used in the present study, so large indeed that no multiplication of H37Ra was required 
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non-vaccinated controls.  Limited though it was,  the immunity persisted  for 
many weeks, but it began to fade shortly after the bacilli used as vaccine had 
disappeared  from the  tissues. 
Granting all these limitations, it nevertheless  appears  profitable  to use the 
mouse for the study of many problems  of antituberculous immunity. Young 
mice, in particular, appear to lend themselves well to tests for the quantitative 
assessment  of vaccines  and of vaccination procedures.  Since all evidence-- 
experimental as well as epidemiological--points  to the conclusion that immunity 
to tuberculosis does not operate through a bactericidal  action on the infecting 
bacilli, but merely or chiefly by restricting their multiplication, it seems certain 
that analysis of the immune mechanisms  requires  the use of techniques  per- 
mitting a quantitative appraisal  of the number of viable bacilli in the tissues. 
In this relation the bacteriological procedures used in the present study would 
seem to constitute a useful adjunct to histological techniques. 
S~ARY 
The immunity induced in mice by vaccination with living attenuated cul- 
tures of tubercle  bacilli was measured by two criteria. 
(a) Increase in survival  time of the vaccinated animals after infection with 
a dose of virulent bacilli sufficient to kill all the unvaccinated controls within 
10 to 20 days. 
(b) Difference in the number of living bacilli recovered from the spleen and 
lungs of vaccinated and normal animals infected with a small dose of virulent 
bacilli. 
The level of immunity induced was found to depend upon the extent of 
multiplication in  vivo  of the  bacilli  used  for vaccination.  This in  turn was 
conditioned by the degree of attenuation characteristic  of the bacterial strain 
used in the preparation of the vaccine,  the amount of vaccine  injected,  the 
route of vaccination, and the time interval between vaccination and challenge 
infection.  It was possible to prevent or retard the development of immunity 
by treating the mice in course of immunization with a drug, isoniazid, capable 
of interrupting the multiplication in ~ivo of the bacilli used as vaccine. 
Although immunity regularly  developed  and lasted for many weeks when 
the proper  conditions  of vaccination were  used,  the  immune response  was 
never sufficient to protect the animals against ultimate death from infection 
with virulent tubercle  bacilli. The prolongation of life in the vaccinated mice 
was not consequent  on a direct bactericidal  effect but rather on a retarded or 
interrupted multiplication of the virulent bacilli in ~ivo. 
The quantitative bacteriological techniques used in the present study would 
appear to be of value for the analysis of certain problems  of immunity, and 
for the appraisal  of vaccines and techniques  of vaccination. 220  r~UNIZATION WITH LMNG TUBERCLE BACILLI 
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